We are live on ! Find out more
GSC

G&S Capital Portfolio holdings

AUM $345M
1-Year Est. Return 32.53%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+32.53%
3 Year Est. Return
+77.18%
5 Year Est. Return
+99.48%
10 Year Est. Return
AUM
$238M
AUM Growth
+$8.41M
Cap. Flow
-$16.8M
Cap. Flow %
-7.03%
Top 10 Hldgs %
32.63%
Holding
132
New
13
Increased
58
Reduced
42
Closed
13

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$18.2M
2
PFE icon
Pfizer
PFE
+$2.8M
3
ITW icon
Illinois Tool Works
ITW
+$2.62M
4
LRCX icon
Lam Research
LRCX
+$2.54M
5
CEG icon
Constellation Energy
CEG
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 10.13%
2 Financials 8.52%
3 Industrials 6.71%
4 Healthcare 4.12%
5 Energy 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
126
McDonald's
MCD
$192B
-1,671
Closed -$420K
NKE icon
127
Nike
NKE
$61.9B
-25,971
Closed -$1.85M
PFE icon
128
Pfizer
PFE
$143B
-96,339
Closed -$2.8M
QCOM icon
129
Qualcomm
QCOM
$155B
-11,380
Closed -$2.37M
STLD icon
130
Steel Dynamics
STLD
$36B
-4,678
Closed -$617K
VB icon
131
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
-1,138
Closed -$260K
VEA icon
132
Vanguard FTSE Developed Markets ETF
VEA
$229B
-4,029
Closed -$206K

Similar funds

G&S Capital's Q3 2024 Portfolio in Review

As of Q3 2024, G&S Capital held 132 positions worth $238M, up 3.7% from $230M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

G&S Capital withdrew a net $16.8M in Q3 2024, closing 13 positions and reducing 42 holdings. Its most notable exit was Pfizer, an estimated $2.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, G&S Capital opened a new position in Invesco S&P 500 Equal Weight ETF worth $2.91M.

  • G&S Capital's largest Q3 2024 buy was Invesco S&P 500 Equal Weight ETF: 16,230 shares worth $2.91M.
  • G&S Capital added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2024, an estimated $3.54M increase.
  • G&S Capital's biggest Q3 2024 reduction was Broadcom, cutting an estimated $18.2M.
  • G&S Capital fully exited Pfizer in Q3 2024, selling an estimated $2.8M.
  • G&S Capital's ten largest holdings make up 33% of its $238M portfolio in Q3 2024.
  • G&S Capital opened 13 new positions and closed 13 in Q3 2024.
  • G&S Capital's portfolio value rose 3.7% quarter-over-quarter to $238M.

Based on G&S Capital's 13F filing for Q3 2024, filed 16 Oct 2024.